Thomas A Mccourt - Net Worth and Insider Trading
Thomas A Mccourt Net Worth
The estimated net worth of Thomas A Mccourt is at least $7 Million dollars as of 2024-05-12. Thomas A Mccourt is the CEO of Ironwood Pharmaceuticals Inc and owns about 832,774 shares of Ironwood Pharmaceuticals Inc (IRWD) stock worth over $6 Million. Thomas A Mccourt is also the Director of Acceleron Pharma Inc and owns about 6,044 shares of Acceleron Pharma Inc (XLRN) stock worth over $1 Million. Details can be seen in Thomas A Mccourt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas A Mccourt has not made any transactions after 2024-02-12 and currently still holds the listed stock(s).
Transaction Summary of Thomas A Mccourt
Thomas A Mccourt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas A Mccourt owns 3 companies in total, including Acceleron Pharma Inc (XLRN) , Ironwood Pharmaceuticals Inc (IRWD) , and Pliant Therapeutics Inc (PLRX) .
Click here to see the complete history of Thomas A Mccourt’s form 4 insider trades.
Insider Ownership Summary of Thomas A Mccourt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XLRN | Acceleron Pharma Inc | 2021-04-19 | director |
| IRWD | Ironwood Pharmaceuticals Inc | 2024-02-12 | Chief Commercial Officer |
| PLRX | Pliant Therapeutics Inc | 2023-03-06 | director |
Thomas A Mccourt Latest Holdings Summary
Thomas A Mccourt currently owns a total of 2 stocks. Among these stocks, Thomas A Mccourt owns 832,774 shares of Ironwood Pharmaceuticals Inc (IRWD) as of February 12, 2024, with a value of $6 Million and a weighting of 84.36%. Thomas A Mccourt also owns 6,044 shares of Acceleron Pharma Inc (XLRN) as of April 19, 2021, with a value of $1 Million and a weighting of 15.64%.
Latest Holdings of Thomas A Mccourt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IRWD | Ironwood Pharmaceuticals Inc | 2024-02-12 | 832,774 | 7.00 | 5,829,418 |
| XLRN | Acceleron Pharma Inc | 2021-04-19 | 6,044 | 178.75 | 1,080,365 |
Holding Weightings of Thomas A Mccourt
Thomas A Mccourt Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas A Mccourt has made a total of 19 transactions in Ironwood Pharmaceuticals Inc (IRWD) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Ironwood Pharmaceuticals Inc is the sale of 177,164 shares on February 12, 2024, which brought Thomas A Mccourt around $3 Million.
According to the SEC Form 4 filings, Thomas A Mccourt has made a total of 2 transactions in Acceleron Pharma Inc (XLRN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Acceleron Pharma Inc is the sale of 7,500 shares on April 19, 2021, which brought Thomas A Mccourt around $894,450.
Insider Trading History of Thomas A Mccourt
- 1
Thomas A Mccourt Trading Performance
Thomas A Mccourt Ownership Network
Thomas A Mccourt Owned Company Details
What does Acceleron Pharma Inc do?
Who are the key executives at Acceleron Pharma Inc?
Thomas A Mccourt is the director of Acceleron Pharma Inc. Other key executives at Acceleron Pharma Inc include EVP & Chief Commercial Officer Sujay Kango , SVP & CFO and Treasurer Kevin F Mclaughlin , and SVP & General Counsel and Sec. Adam M Veness .
Acceleron Pharma Inc (XLRN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acceleron Pharma Inc (XLRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acceleron Pharma Inc (XLRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acceleron Pharma Inc (XLRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acceleron Pharma Inc Insider Transactions
Thomas A Mccourt Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas A Mccourt. You might contact Thomas A Mccourt via mailing address: C/o Ironwood Pharmaceuticals, Inc., 100 Summer Street, Suite 2300, Boston Ma 02110.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
